Non-small-cell lung cancer

Non-small-cell lung cancer
Other namesNon-small-cell lung carcinoma
Micrograph of a squamous carcinoma, a type of non-small-cell lung carcinoma, FNA specimen, Pap stain.
SpecialtyOncology 

Non-small-cell lung cancer (NSCLC), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers.[1][2][3] As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy has been used increasingly both preoperatively (neoadjuvant chemotherapy) and postoperatively (adjuvant chemotherapy).

  1. ^ Khajuria O, Sharma N (1 December 2021). "Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology". Advances in Cancer Biology - Metastasis. 3 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
  2. ^ Non-Small Cell Lung Cancer at eMedicine
  3. ^ "What Is Non-Small Cell Lung Cancer?". www.cancer.org. Archived from the original on 17 January 2017. Retrieved 23 January 2016.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.